About Journal of Personalized Medicine

Aims

Journal of Personalized Medicine (JPM; ISSN 2075-4426) is an international, open access journal aimed at bringing all aspects of personalized medicine to one platform. JPM publishes cutting edge, innovative preclinical and translational scientific research and technologies related to personalized medicine (e.g., precision medicine, pharmacogenomics/proteomics, systems biology, ‘omics association analysis). Personalized medicine covers the processes of disease development, such as disease risk factors, disease epidemiology and prevention, disease diagnosis, disease treatment, and disease prognosis after treatment.

For a comprehensive perspective of primary research, commentaries, and reviews related to personalized medicine, also termed precision medicine, JPM aims to integrate expertise from the molecular and translational sciences, therapeutics and diagnostics, as well as discussions of regulatory, social, ethical and policy aspects. We provide a forum to bring together academic and clinical researchers, biotechnology, diagnostic and pharmaceutical companies, health professionals, regulatory and ethical experts, and government and regulatory authorities.

Scope

Topics of interest with a view towards personalized medicine include (but are not limited to) the following:

• Omics-based studies of disease risk, disease prognosis, and response to therapy
• Biomarker identification and application
• Drug target discovery and integration with individualized therapy
• Pharmacogenomics – genetics and biochemistry of drug uptake, action, and metabolism
• Prediction-based drug safety
• Novel therapeutics: genetic-based, nanotechnology, targeting strategies
• Advancements in Technologies and Resources
• Genetic testing, sequencing technologies, and molecular diagnostics
• Expression analysis, metabolomics, proteomics
• Microbiomes
• Genome-wide association studies
• Bioinformatics and health informatics
• Biostatistics
• Artificial intelligence and machine learning
• Personalization of omics-based non-drug related health interventions
• Regulation and bioethics in personalized medicine
• Personalized researches for special populations: pediatrics, adolescents, elderly, etc.
• Disease risk factors
• Diagnostics in imaging, molecular, pathology, devices assistant, laboratory and others
• Personalized medicine in preclinical and clinical medicine, various therapy methods and multidisciplinary therapeutic strategies

MDPI Publication Ethics Statement

MDPI is a member of the Committee on Publication Ethics (COPE). MDPI takes the responsibility to enforce a rigorous peer-review together with strict ethical policies and standards to ensure to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, inappropriate authorship credit, and the like, do arise. MDPI takes such publishing ethics issues very seriously and our editors are trained to proceed in such cases with a zero tolerance policy. To verify the originality of content submitted to our journals, we use iThenticate to check submissions against previous publications.

Book Reviews

Authors and publishers are encouraged to send review copies of their recent related books to the following address. Received books will be listed as Books Received within the journal's News & Announcements section.

MDPI
Grosspeteranlage 5
CH-4052 Basel
Switzerland

Copyright / Open Access

Articles published in JPM will be Open-Access articles distributed under the terms and conditions of the Creative Commons Attribution License (CC BY). The copyright is retained by the author(s). MDPI will insert the following note at the end of the published text:

Reprints

Reprints may be ordered. Please contact for more information on how to order reprints.

Announcement and Advertisement

Announcements regarding academic activities such as conferences are published for free in the News & Announcements section of the journal. Advertisement can be either published or placed on the pertinent website. Contact e-mail address is .

Editorial Office

For further MDPI contacts, see here.